Physician-Supervised Peptide Therapy in New York

Peptides are short chains of amino acids that act as signaling molecules in many biological processes. Some peptide-based medications are FDA approved for specific medical indications, while other peptide compounds may be investigational, unapproved, or subject to regulatory restrictions.

For how this differs from prescription GLP-1 treatment, see peptide therapy vs. GLP-1 weight-loss treatment.

PeptideDoc uses a physician-led evaluation process that may consider:

• Medical history
• Current medications
• Treatment goals
• Symptoms
• Laboratory findings when appropriate
• Contraindications
• Available clinical evidence
• Regulatory status
• Potential risks and alternatives

Peptide-based treatments may affect important physiological pathways and can involve side effects, contraindications, drug interactions, and monitoring requirements. Physician oversight helps determine whether a therapy is appropriate and how treatment should be monitored.

No. FDA approval varies by medication and indication. Some peptide-based medications are FDA approved for specific uses, while others are investigational or unapproved. Compounded medications are not FDA approved.

Read more in our FDA status and safety FAQs.

Treatment recommendations are individualized based on the patient's medical history, health goals, clinical findings, treatment response, and physician assessment. PeptideDoc does not use a one-size-fits-all peptide protocol.

Peptide-based care may sometimes be considered alongside medical weight management, depending on the individual patient.

Follow-up may include review of symptoms, treatment response, side effects, laboratory findings where appropriate, and adjustments to the treatment plan.

Care is provided from our Bayside, NY office. See also what to look for in a peptide clinic.